Browse the latest research summaries in the field of urology for spinal cord injury patients and caregivers.
Showing 11-20 of 407 results
World J Mens Health, 2025 • January 1, 2025
This review summarizes the role of autophagy in erectile dysfunction (ED), focusing on how it affects endothelial cells, smooth muscle cells, penile fibrosis, and nerve injury. It highlights the poten...
KEY FINDING: Autophagy plays a significant role in maintaining the homeostasis of corpus cavernosum endothelial cells (CCECs) and determining their survival and death, influencing ED, particularly in diabetes mellitus-induced ED (DMED).
European Urology Open Science, 2024 • October 3, 2024
This systematic review and meta-analysis aimed to investigate the incidence of and risk factors for urinary stones in patients with spinal cord injury (SCI). The study found a high incidence of urinar...
KEY FINDING: The overall incidence of urinary stones after SCI was found to be 16.6%.
International Neurourology Journal, 2024 • December 31, 2024
This retrospective study investigates the effectiveness of implantable neuromodulation for patients with neurogenic lower urinary tract dysfunction (NLUTD) at a single institution from 2008 to 2020. T...
KEY FINDING: Neuromodulation, both sacral and pudendal, is a feasible and effective treatment option for NLUTD, with a significant percentage of patients experiencing symptom improvement.
International Journal of Surgery Case Reports, 2025 • January 23, 2025
This case report presents a rare instance of urogenital myiasis in a 40-year-old male with a spinal cord injury and long-term indwelling urinary catheter, a combination not frequently reported in exis...
KEY FINDING: A 40-year-old male with a spinal cord injury developed urogenital myiasis due to long-term catheter use, presenting with maggots at the urethral meatus.
J. Clin. Med., 2025 • February 6, 2025
The study investigated patients’ attitudes toward early sacral neuromodulation (SNM) for neurogenic lower urinary tract dysfunction (nLUTD) after spinal cord injury (SCI). Results showed that a signif...
KEY FINDING: 61.9% of patients stated they would have consented to early therapy prior to the emergence of their neurogenic lower urinary tract dysfunction.
World Journal of Urology, 2025 • March 21, 2025
The study examined the impact of botulinum toxin A detrusor injections (BoNT/A-DI) on blood pressure in patients with overactive bladder (OAB) or neurogenic bladder, focusing on cardiovascular risk fa...
KEY FINDING: Systolic blood pressure increased significantly by an average of 9.8 mmHg across all patients during the procedure.
The Journal of Spinal Cord Medicine, 2022 • November 1, 2022
This case report describes the successful treatment of pyocystis with a single amikacin bladder instillation in a 59-year-old male with paraplegia and anuria. The patient, who had recurrent episodes o...
KEY FINDING: A single-dose intravesical instillation of amikacin 25 mg/100 mL successfully treated pyocystis in an anuric SCI patient with recurrent autonomic dysreflexia.
The Journal of Spinal Cord Medicine, 2023 • January 1, 2023
The study investigated the impact of activity-based recovery training (ABRT) and desmopressin (DDAVP) on spinal cord injury (SCI)-induced polyuria in Wistar rats. ABRT was found to reduce urine produc...
KEY FINDING: Seventy sessions of ABRT reduced urine overproduction in SCI rats, but not to pre-SCI baseline levels.
BMC Urology, 2022 • September 5, 2022
This scoping review examined the impact of hydrophilic versus non-hydrophilic intermittent catheters on various outcomes in patients with urinary retention. The review included 77 articles and found t...
KEY FINDING: HCICs generally lead to greater UTI reduction and improved satisfaction, cost-effectiveness, and quality of life.
J. Clin. Med., 2022 • October 4, 2022
This retrospective study assessed the long-term satisfaction and complications of various urinary incontinence treatments in 700 chronic SCI patients. The goal was to determine which bladder managemen...
KEY FINDING: High satisfaction rates were observed after detrusor Botox injection (81.1%), augmentation enterocystoplasty (91.4%), autoaugmentation (80%), Kock pouch diversion, and continent cystostomy (all 100%).